Christopher Metzger

2.7k total citations · 2 hit papers
21 papers, 1.5k citations indexed

About

Christopher Metzger is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher Metzger has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher Metzger's work include Peripheral Artery Disease Management (8 papers), Vascular Procedures and Complications (6 papers) and Aortic aneurysm repair treatments (5 papers). Christopher Metzger is often cited by papers focused on Peripheral Artery Disease Management (8 papers), Vascular Procedures and Complications (6 papers) and Aortic aneurysm repair treatments (5 papers). Christopher Metzger collaborates with scholars based in United States, Austria and Germany. Christopher Metzger's co-authors include Michael R. Jaff, Prakash Krishnan, Thomas Zeller, Antonio Micari, Gunnar Tepe, Dierk Scheinert, Marianne Brodmann, Peter A. Schneider, John R. Laird and David J. Cohen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetic Medicine.

In The Last Decade

Christopher Metzger

20 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

2014 477 citations Gunnar Tepe, John R. Laird et al. Circulation profile →
Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions

2015 259 citations John R. Laird, Peter A. Schneider et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Metzger United States	12	1.2k	1.1k	362	199	148	21	1.5k
T. Hartshorne United Kingdom	20	926 0.7×	832 0.7×	438 1.2×	362 1.8×	196 1.3×	43	1.4k
Ross T. Lyon United States	27	1.2k 1.0×	2.1k 1.9×	830 2.3×	139 0.7×	214 1.4×	59	2.4k
G Galzerano Italy	16	435 0.4×	615 0.5×	253 0.7×	51 0.3×	137 0.9×	68	819
Nicola Troisi Italy	18	868 0.7×	1.0k 0.9×	325 0.9×	47 0.2×	99 0.7×	112	1.3k
Sven Bräunlich Germany	20	1.8k 1.4×	1.8k 1.5×	138 0.4×	270 1.4×	175 1.2×	29	2.0k
Mary Beth Childs United States	7	552 0.4×	685 0.6×	112 0.3×	168 0.8×	85 0.6×	11	883
Yvonne Bausback Germany	20	1.4k 1.1×	1.4k 1.2×	85 0.2×	254 1.3×	111 0.8×	39	1.6k
Kurt R. Wengerter United States	27	1.6k 1.3×	1.6k 1.4×	435 1.2×	191 1.0×	45 0.3×	61	2.0k
Pasqualino Sirignano Italy	19	475 0.4×	942 0.8×	435 1.2×	40 0.2×	199 1.3×	117	1.1k
Jürgen Verbist Belgium	19	788 0.6×	1.1k 1.0×	282 0.8×	103 0.5×	318 2.1×	58	1.3k

Countries citing papers authored by Christopher Metzger

Since Specialization

Citations

This map shows the geographic impact of Christopher Metzger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Metzger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Metzger more than expected).

Fields of papers citing papers by Christopher Metzger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Metzger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Metzger. The network helps show where Christopher Metzger may publish in the future.

Co-authorship network of co-authors of Christopher Metzger

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Metzger. A scholar is included among the top collaborators of Christopher Metzger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Metzger. Christopher Metzger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holden, Andrew, Andrew Hill, Rahul Sakhuja, et al.. (2023). Long-Term Follow-up of Subjects With Iliac Occlusive Disease Treated With the Viabahn VBX Balloon-Expandable Endoprosthesis. Journal of Endovascular Therapy. 32(1). 68–76. 5 indexed citations

Liu, Yulun, Shirling Tsai, Mitul Patel, et al.. (2022). ENDOVASCULAR TREATMENT AND OUTCOMES FOR FEMOROPOPLITEAL IN-STENT RESTENOSIS: INSIGHTS FROM THE XLPAD REGISTRY. Journal of the American College of Cardiology. 79(9). 814–814. 2 indexed citations

Patel, Kunal, Yulun Liu, Farshid Etaee, et al.. (2021). Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry. Circulation Cardiovascular Interventions. 14(11). e010635–e010635. 7 indexed citations

Metzger, Christopher, et al.. (2019). Lessons for building creative economies. 1 indexed citations

Kereiakes, Dean J., Stephen G. Ellis, Christopher Metzger, et al.. (2017). 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds. Journal of the American College of Cardiology. 70(23). 2852–2862. 194 indexed citations

Garcia, Lawrence A., Kenneth Rosenfield, Christopher Metzger, et al.. (2017). SUPERB final 3‐year outcomes using interwoven nitinol biomimetic supera stent. Catheterization and Cardiovascular Interventions. 89(7). 1259–1267. 76 indexed citations

Bismuth, Jean, et al.. (2017). Pivotal Study of a Next-Generation Balloon-Expandable Stent-Graft for Treatment of Iliac Occlusive Disease. Journal of Endovascular Therapy. 24(5). 629–637. 45 indexed citations

Burket, Mark W., Marianne Brodmann, Christopher Metzger, Kongteng Tan, & Michael R. Jaff. (2016). Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions. Journal of Vascular and Interventional Radiology. 27(11). 1650–1656.e1. 3 indexed citations

Laird, John R., Peter A. Schneider, Gunnar Tepe, et al.. (2015). Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions. Journal of the American College of Cardiology. 66(21). 2329–2338. 259 indexed citations breakdown →

10.

Mintz, Gary S., Bernhard Witzenbichler, Christopher Metzger, et al.. (2014). LONG-TERM CLINICAL IMPACT OF ACUTE STENT MALAPPOSITION: AN ADAPT-DES IVUS SUBSTUDY. Journal of the American College of Cardiology. 63(12). A1672–A1672.

11.

Shishehbor, Mehdi H., Sridhar Venkatachalam, William A. Gray, et al.. (2014). Experience and Outcomes With Carotid Artery Stenting. JACC: Cardiovascular Interventions. 7(11). 1307–1317. 20 indexed citations

12.

Tepe, Gunnar, John R. Laird, Peter A. Schneider, et al.. (2014). Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease. Circulation. 131(5). 495–502. 477 indexed citations breakdown →

13.

Stone, Gregg W., Akiko Maehara, Bernhard Witzenbichler, et al.. (2013). INTRACORONARY ABCIXIMAB AND ASPIRATION THROMBECTOMY DURING PRIMARY PCI FOR ANTERIOR STEMI: ONE–YEAR RESULTS FROM THE RANDOMIZED INFUSE–AMI TRIAL. Journal of the American College of Cardiology. 61(10). E1853–E1853. 2 indexed citations

14.

Rinaldi, Michael J., Ajay J. Kirtane, Ke Xu, et al.. (2013). IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY. Journal of the American College of Cardiology. 61(10). E1857–E1857. 3 indexed citations

15.

Nussbaum, Marcy, James Hermiller, Zachary I. Hodes, et al.. (2011). An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a?large prospective multicentre registry, the STENT Group. EuroIntervention. 6(8). 942–948. 4 indexed citations

16.

Grant, Arthur C., Christopher J. White, Gary M. Ansel, et al.. (2009). Safety and efficacy of carotid stenting in the very elderly. Catheterization and Cardiovascular Interventions. 75(5). 651–655. 31 indexed citations

17.

Massop, Douglas W., Rajesh Davé, Christopher Metzger, et al.. (2008). Stenting and Angioplasty with Protection in Patients at High‐Risk for Endarterectomy: SAPPHIRE Worldwide Registry First 2,001 Patients. Catheterization and Cardiovascular Interventions. 73(2). 129–136. 117 indexed citations

18.

Kirtane, Ajay J., Eugene R. Heyman, Christopher Metzger, Jeffrey A. Breall, & Joseph P. Carrozza. (2008). Correlates of Adverse Events During Saphenous Vein Graft Intervention With Distal Embolic Protection. JACC: Cardiovascular Interventions. 1(2). 186–191. 11 indexed citations

19.

Carrozza, Joseph P., et al.. (2005). Randomized Evaluation of the TriActiv Balloon-Protection Flush and Extraction System for the Treatment of Saphenous Vein Graft Disease. Journal of the American College of Cardiology. 46(9). 1677–1683. 48 indexed citations

20.

Chantelau, E., et al.. (1996). Antibiotic Treatment for Uncomplicated Neuropathic Forefoot Ulcers in Diabetes: a Controlled Trial. Diabetic Medicine. 13(2). 156–159. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact